CITIUS PHARMAC (Germany) Volatility
| 47N Stock | EUR 3.29 0.00 0.00% |
CITIUS PHARMAC DL secures Sharpe Ratio (or Efficiency) of -0.2, which signifies that the company had a -0.2% return per unit of volatility over the last 3 months. CITIUS PHARMAC DL exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CITIUS PHARMAC's risk adjusted performance of (0.14), and Mean Deviation of 4.81 to double-check the risk estimate we provide. Key indicators related to CITIUS PHARMAC's volatility include:
720 Days Market Risk | Chance Of Distress | 720 Days Economic Sensitivity |
CITIUS PHARMAC Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of CITIUS daily returns, and it is calculated using variance and standard deviation. We also use CITIUS's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of CITIUS PHARMAC volatility.
CITIUS |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as CITIUS PHARMAC can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of CITIUS PHARMAC at lower prices to lower their average cost per share. Similarly, when the prices of CITIUS PHARMAC's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving together with CITIUS Stock
| 0.65 | NOVA | Novo Nordisk AS | PairCorr |
| 0.62 | CSJ | CSL Limited | PairCorr |
| 0.82 | 0QF | Moderna | PairCorr |
| 0.72 | PQ9 | PT Bank Mandiri | PairCorr |
Moving against CITIUS Stock
| 0.67 | E908 | Lyxor 1 | PairCorr |
| 0.54 | DBPE | Xtrackers LevDAX | PairCorr |
| 0.39 | 1FW1 | WUXI BIOLOGICS UNSPADR2 | PairCorr |
| 0.37 | 22UA | BioNTech SE | PairCorr |
| 0.32 | VX1 | Vertex Pharmaceuticals | PairCorr |
CITIUS PHARMAC Market Sensitivity And Downside Risk
CITIUS PHARMAC's beta coefficient measures the volatility of CITIUS stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents CITIUS stock's returns against your selected market. In other words, CITIUS PHARMAC's beta of 0.0681 provides an investor with an approximation of how much risk CITIUS PHARMAC stock can potentially add to one of your existing portfolios. CITIUS PHARMAC DL is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure CITIUS PHARMAC's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact CITIUS PHARMAC's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze CITIUS PHARMAC DL Demand TrendCheck current 90 days CITIUS PHARMAC correlation with market (Dow Jones Industrial)CITIUS Beta |
CITIUS standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 7.83 |
It is essential to understand the difference between upside risk (as represented by CITIUS PHARMAC's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of CITIUS PHARMAC's daily returns or price. Since the actual investment returns on holding a position in citius stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in CITIUS PHARMAC.
CITIUS PHARMAC DL Stock Volatility Analysis
Volatility refers to the frequency at which CITIUS PHARMAC stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with CITIUS PHARMAC's price changes. Investors will then calculate the volatility of CITIUS PHARMAC's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of CITIUS PHARMAC's volatility:
Historical Volatility
This type of stock volatility measures CITIUS PHARMAC's fluctuations based on previous trends. It's commonly used to predict CITIUS PHARMAC's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for CITIUS PHARMAC's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on CITIUS PHARMAC's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. CITIUS PHARMAC DL Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
CITIUS PHARMAC Projected Return Density Against Market
Assuming the 90 days horizon CITIUS PHARMAC has a beta of 0.0681 . This suggests as returns on the market go up, CITIUS PHARMAC average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding CITIUS PHARMAC DL will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to CITIUS PHARMAC or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that CITIUS PHARMAC's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a CITIUS stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
CITIUS PHARMAC DL has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a CITIUS PHARMAC Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.CITIUS PHARMAC Stock Risk Measures
Assuming the 90 days horizon the coefficient of variation of CITIUS PHARMAC is -511.09. The daily returns are distributed with a variance of 61.32 and standard deviation of 7.83. The mean deviation of CITIUS PHARMAC DL is currently at 4.87. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.73
α | Alpha over Dow Jones | -1.57 | |
β | Beta against Dow Jones | 0.07 | |
σ | Overall volatility | 7.83 | |
Ir | Information ratio | -0.21 |
CITIUS PHARMAC Stock Return Volatility
CITIUS PHARMAC historical daily return volatility represents how much of CITIUS PHARMAC stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company shows 7.8308% volatility of returns over 90 . By contrast, Dow Jones Industrial accepts 0.7299% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About CITIUS PHARMAC Volatility
Volatility is a rate at which the price of CITIUS PHARMAC or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of CITIUS PHARMAC may increase or decrease. In other words, similar to CITIUS's beta indicator, it measures the risk of CITIUS PHARMAC and helps estimate the fluctuations that may happen in a short period of time. So if prices of CITIUS PHARMAC fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products targeting medical needs with a focus on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. CITIUS PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10 people.
CITIUS PHARMAC's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on CITIUS Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much CITIUS PHARMAC's price varies over time.
3 ways to utilize CITIUS PHARMAC's volatility to invest better
Higher CITIUS PHARMAC's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of CITIUS PHARMAC DL stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. CITIUS PHARMAC DL stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of CITIUS PHARMAC DL investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in CITIUS PHARMAC's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of CITIUS PHARMAC's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
CITIUS PHARMAC Investment Opportunity
CITIUS PHARMAC DL has a volatility of 7.83 and is 10.73 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of CITIUS PHARMAC DL is higher than 69 percent of all global equities and portfolios over the last 90 days. You can use CITIUS PHARMAC DL to protect your portfolios against small market fluctuations. The stock experiences a normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of CITIUS PHARMAC to be traded at €3.26 in 90 days.Significant diversification
The correlation between CITIUS PHARMAC DL and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CITIUS PHARMAC DL and DJI in the same portfolio, assuming nothing else is changed.
CITIUS PHARMAC Additional Risk Indicators
The analysis of CITIUS PHARMAC's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in CITIUS PHARMAC's investment and either accepting that risk or mitigating it. Along with some common measures of CITIUS PHARMAC stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.14) | |||
| Market Risk Adjusted Performance | (22.98) | |||
| Mean Deviation | 4.81 | |||
| Coefficient Of Variation | (499.50) | |||
| Standard Deviation | 7.77 | |||
| Variance | 60.4 | |||
| Information Ratio | (0.21) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
CITIUS PHARMAC Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against CITIUS PHARMAC as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. CITIUS PHARMAC's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, CITIUS PHARMAC's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to CITIUS PHARMAC DL.
Complementary Tools for CITIUS Stock analysis
When running CITIUS PHARMAC's price analysis, check to measure CITIUS PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CITIUS PHARMAC is operating at the current time. Most of CITIUS PHARMAC's value examination focuses on studying past and present price action to predict the probability of CITIUS PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CITIUS PHARMAC's price. Additionally, you may evaluate how the addition of CITIUS PHARMAC to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |